Glycaemic and insulinaemic properties of some German honey varieties

Deibert, Peter; König, Daniel; Kloock, B.; Groenefeld, M; Berg, Aloys

doi:10.1038/ejcn.2009.103

Cited by 54 publications

(41 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Some of these studies investigated the acute effect of honey 82, 83, 129, 133, 135, 136, 154, 155 whereas only very few studies evaluated the effect of honey over a long duration 120. This may influence the outcome, leading to significant findings in some studies and lack of significant results in others.…”

Section: Relative Strengths and Weaknesses Of Some Of These Studiesmentioning

confidence: 99%

Honey - A Novel Antidiabetic Agent

Erejuwa

Sulaiman²,

Wahab³

2012

Int. J. Biol. Sci.

128

120

View full text Add to dashboard Cite

Diabetes mellitus remains a burden worldwide in spite of the availability of numerous antidiabetic drugs. Honey is a natural substance produced by bees from nectar. Several evidence-based health benefits have been ascribed to honey in the recent years. In this review article, we highlight findings which demonstrate the beneficial or potential effects of honey in the gastrointestinal tract (GIT), on the gut microbiota, in the liver, in the pancreas and how these effects could improve glycemic control and metabolic derangements. In healthy subjects or patients with impaired glucose tolerance or diabetes mellitus, various studies revealed that honey reduced blood glucose or was more tolerable than most common sugars or sweeteners. Pre-clinical studies provided more convincing evidence in support of honey as a potential antidiabetic agent than clinical studies did. The not-too-impressive clinical data could mainly be attributed to poor study designs or due to the fact that the clinical studies were preliminary. Based on the key constituents of honey, the possible mechanisms of action of antidiabetic effect of honey are proposed. The paper also highlights the potential impacts and future perspectives on the use of honey as an antidiabetic agent. It makes recommendations for further clinical studies on the potential antidiabetic effect of honey. This review provides insight on the potential use of honey, especially as a complementary agent, in the management of diabetes mellitus. Hence, it is very important to have well-designed, randomized controlled clinical trials that investigate the reproducibility (or otherwise) of these experimental data in diabetic human subjects.

show abstract

Section: Relative Strengths and Weaknesses Of Some Of These Studiesmentioning

confidence: 99%

Honey - A Novel Antidiabetic Agent

Erejuwa

Sulaiman²,

Wahab³

2012

Int. J. Biol. Sci.

128

120

View full text Add to dashboard Cite

show abstract

“…There is a somewhat revival for the use of honey focusing on its health promoting benefits; it has been assumed that honey has a variety of positive nutritional and health effects if consumed at levels of 50 to 80 g per serving [19]. Even though honey is a carbohydrate-rich food, its glycemic index varies across a wide range, depending on the botanical source and its glucose: fructose ratio [28]. Additionally, honey contains various oligosaccharides [6] and small amounts of proteins, enzymes, amino acids, minerals, trace elements, vitamins, …”

Section: Bioactive Ingredients Of Syhf and Their Molecular Basis For mentioning

confidence: 99%

The effect of a soy-yoghurt-honey product on excess weight and related health risk factors - A review

Koohkan¹,

McCarthy²,

Berg³

2017

JNHFS

View full text Add to dashboard Cite

achieve this goal, supervised programs can be applied over a period of at least 6 months delivered by an interdisciplinary team of physicians, psychologists and group behavior consultants and nutritionists. This approach produces healthy modifications in diet and exercise for an individual's every day practice [10].Even if such a program is insufficient to prove the long-term success, the significant findings in obese adults confirms that using modified lifestyle interventions are at least comparable with the results of pharmacological interventions after 12-months [66]. Nevertheless, it is discouraging knowing the level of success in weight loss programs while only a very small number of obese patients can be motivated to participate in a lifestyle intervention program [25].There is agreement that long-term therapeutic lifestyle changes (TLC) such as dietary behavior reformations and increasing daily physical activity, are the cornerstones in the prevention and management of obesity and its related health risk factors and are often combined with cognitive behavior modification techniques [10,85]. Furthermore, the use of meal replacements has been accepted as an effective therapeutic strategy for weight loss, particularly in the beginning of an intervention [4,5,26,83,85].Dietary approaches can achieve as much weight loss in obese outpatients as has been reported for the most successful drug treatments, but compliance with the prescribed diet can be poor unless the dietary recommendations are simple to follow [73]. Moreover, weight loss interventions utilizing a meal replacement together with dietary counselling and increased physical activity have led to substantial and significant favorable reductions in anthropometric measurements and metabolic risk factors while preserving skeletal muscle mass [7,8]. T h e following review will specially focus on the efficiency of a clinically proven meal replacement product which is commercially available as a soy-yoghurt-honey formula (SYHF; Almased®) against overweight, obesity and its related health risks. AbstractThere is an agreement that long-term Therapeutic Lifestyle Changes (TLC) such as dietary behavior reformations and increasing daily physical activity, are the cornerstones in the prevention and management of obesity and its related health risk factors. Furthermore, the use of meal replacement diet has been accepted as an effective therapeutic strategy for a successful weight loss, particularly in the beginning of an intervention. The following review will specially focus on the efficiency of a clinically approved meal replacement product which is commercially available as a Soy-Yoghurt-Honey Formula (SYHF) which can be used to prevent, treat or manage overweight, obesity and its related health risks. The mentioned positive effects come not only by formula's low glycemic index as well as low caloric characteristics, but by its biologically active components such as soy isoflavones and soy and milk biological active peptides as well as antioxidants, enzymes and o...

show abstract

“…A few studies have shown that honey has a low glycaemic index (GI) and peak incremental index (PII) (Deibert et al 2010;Abdulrhman et al 2011). Both GI and PII are the measures on the effects of food on the blood glucose level.…”

Section: Role Of Honey In Diabetesmentioning

confidence: 99%

“…However, the GI and PII differ between different types of honey based on different floral sources. The higher the fructose-glucose ratio of a type of honey, the lower is its GI (Deibert et al 2010). Low GI diet can improve overall glycaemic control and also reduce postprandial hyperglycaemia (Abdulrhman et al 2011).…”

Section: Role Of Honey In Diabetesmentioning

confidence: 99%